Tumour necrosis factor receptor-1 associated periodic syndrome (TRAPS)-related AA amyloidosis: a national case series and systematic review.

Jeremie Delaleu Samuel DeshayesFrancois RodriguesLea SaveyEtienne RivièreNicolas Martin SilvaAchille AoubaSerge AmselemMarion RabantGilles GrateauIrina GiurgeaStéphanie Ducharme-Bénard

Published in: Rheumatology (Oxford, England) (2021)

TRAPS is revealed by AA in most cases. Therefore, clinical features of TRAPS should be screened for in AA patients. IL-1 antagonist can help to normalize inflammation and to preserve renal function.

Keyphrases

systematic review
end stage renal disease
ejection fraction
newly diagnosed
chronic kidney disease
oxidative stress
meta analyses
peritoneal dialysis
prognostic factors
case report
patient reported outcomes
binding protein